6UB
amlodipine
| Created: | 2016-06-27 |
| Last modified: | 2020-06-05 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 53 |
| Chiral Atom Count | 1 |
| Bond Count | 54 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | amlodipine |
| Synonyms | ~{O}3-ethyl ~{O}5-methyl (4~{S})-2-(2-azanylethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Systematic Name (OpenEye OEToolkits) | ~{O}3-ethyl ~{O}5-methyl (4~{S})-2-(2-azanylethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Formula | C20 H25 Cl N2 O5 |
| Molecular Weight | 408.876 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CCOC(=O)C1=C(COCCN)NC(=C([CH]1c2ccccc2Cl)C(=O)OC)C |
| SMILES | OpenEye OEToolkits | 2.0.5 | CCOC(=O)C1=C(NC(=C(C1c2ccccc2Cl)C(=O)OC)C)COCCN |
| Canonical SMILES | CACTVS | 3.385 | CCOC(=O)C1=C(COCCN)NC(=C([C@@H]1c2ccccc2Cl)C(=O)OC)C |
| Canonical SMILES | OpenEye OEToolkits | 2.0.5 | CCOC(=O)C1=C(NC(=C([C@@H]1c2ccccc2Cl)C(=O)OC)C)COCCN |
| InChI | InChI | 1.03 | InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3/t17-/m0/s1 |
| InChIKey | InChI | 1.03 | HTIQEAQVCYTUBX-KRWDZBQOSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under aCreative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB09237 |
|---|---|
| Name | Levamlodipine |
| Groups |
|
| Description | Levamlodipine, also known as S-amlodipine, is a pharmacologically active enantiomer of [amlodipine], an antihypertensive medication.[L10833] Levamlodipine belongs to the dihydropyridine group of calcium channel blockers.[L10833] This medication was first marketed in Russia and India before being granted FDA approval.[L1484] The names S-amlodipine and levamlodipine may be used interchangeably as both substances are the same, however.[L10833] As a racemic mixture, amlodipine contains (R) and (S)-amlodipine isomers, but only (S)-amlodipine as the active moiety possesses therapeutic activity.[A188940] Levamlodipine was granted FDA approval on 19 December 2019.[L10833] |
| Synonyms |
|
| Brand Names |
|
| Indication | Levamlodipine is indicated alone or in combination to treat hypertension in adults and children.[L10833] |
| Categories |
|
| ATC-Code | C08CA17 |
| CAS number | 103129-82-4 |
Drug Targets
DrugBank data are sourced from datasets licensed under aCreative Common's Attribution-NonCommercial 4.0 International License
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, JewisonT, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL2111097 |
| PubChem | 9822750 |
| ChEMBL | CHEMBL2111097 |
| ChEBI | CHEBI:53796 |
| CCDC/CSD | XOZRUZ |
- RCSB PDB is hosted by
- RCSB PDB is a member of
- RCSB Partners
- Nucleic Acid Knowledgebase
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.